<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hoyle, Brian</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Saver, Jeffrey L.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Stroke Neuroprotection of Prehospital Magnesium Sulfate Explored</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-04-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">14-15</style></pages><abstract><style  face="normal" font="default" size="100%">Early intervention is critical for stroke care. The physiological and neuroprotective prowess of magnesium has been amply demonstrated in animal models of stroke. Magnesium sulfate administered to patients &lt;2 hours after stroke fails to provide neuroprotection, according to the primary findings of the Field Administration of Stroke Therapy—Magnesium [FAST-MAG] trial.</style></abstract><number><style face="normal" font="default" size="100%">1</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>